Cut-off value of white blood cell count in the diagnosis of early-onset sepsis in neonates
HAO Ying-Xia, YU Jia-Lin
Department of Neonatology, Children's Hospital of Chongqing Medical University/Ministry of Education Key Laboratory of Child Development and Disorders/National Clinical Research Center for Child Health and Disorders/China International Science and Technology Cooperation Base of Child Development and Critical Disorders/Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
Abstract Objective To study the clinical significance and cut-off value of white blood cell (WBC) count in the diagnosis of early-onset sepsis (EOS) in neonates. Methods A retrospective analysis was performed on 306 neonates with EOS who were admitted from January 2019 to March 2020. A total of 580 children without infection who were admitted during the same period of time were enrolled as the control group. General status and WBC count were compared between the two groups. The diagnostic value of WBC count was analyzed based on the diagnostic and therapeutic protocol of neonatal sepsis in 2003 (referred to as the 2003 diagnostic and therapeutic protocol) and the expert consensus on the diagnosis and treatment of neonatal sepsis (2019 edition) (referred to as the 2019 expert consensus). Results According to the two different diagnosis and treatment protocols, the statistical analysis showed that WBC count had a relatively positive rate (51.3% and 32.0% respectively) but a relatively high specificity (93.3% and 98.6% respectively). The receiver operating characteristic (ROC) curve analysis showed that the area under the ROC curve of WBC count in the 2003 diagnostic and therapeutic protocol was larger than that in the 2019 expert consensus (P < 0.05). Conclusions The cut-off value of WBC ≥ 25×109/L in the 2003 diagnostic and therapeutic protocol is more reasonable in the diagnosis of EOS.
Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis:a systematic review[J]. Lancet Respir Med, 2018, 6(3):223-230.
[2]
Al-Shamahy HA, Sabrah AA, Al-Robasi AB, et al. Types of bacteria associated with neonatal sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their antimicrobial profile[J]. Sultan Qaboos Univ Med J, 2012, 12(1):48-54.
[3]
Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England:the NeonIN surveillance network[J]. Arch Dis Child Fetal Neonatal Ed, 2011, 96(1):F9-F14.
[4]
Kohli-Kochhar R, Omuse G, Revathi G. A ten-year review of neonatal bloodstream infections in a tertiary private hospital in Kenya[J]. J Infect Dev Ctries, 2011, 5(11):799-803.
[5]
Sgro M, Shah PS, Campbell D, et al. Early-onset neonatal sepsis:rate and organism pattern between 2003 and 2008[J]. J Perinatol, 2011, 31(12):794-798.
[6]
Morioka I, Morikawa S, Miwa A, et al. Culture-proven neonatal sepsis in Japanese neonatal care units in 2006-2008[J]. Neonatology, 2012, 102(1):75-80.
[7]
Hornik CP, Benjamin DK, Becker KC, et al. Use of the complete blood cell count in early-onset neonatal sepsis[J]. Pediatr Infect Dis J, 2012, 31(8):799-802.
Wang J, Yu J, Fan J, et al. Evaluation of altitude-appropriate reference ranges for neutrophils in diagnosis of sepsis in very low birth weight infants:a multicenter retrospective study[J]. PLoS One, 2017, 12(2):e0171571.
[11]
Weston EJ, Pondo T, Lewis MM, et al. The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008[J]. Pediatr Infect Dis J, 2011, 30(11):937-941.
[12]
Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis:the burden of group B streptococcal and E. coli disease continues[J]. Pediatrics, 2011, 127(5):817-826.
[13]
Meem M, Modak JK, Mortuza R, et al. Biomarkers for diagnosis of neonatal infections:a systematic analysis of their potential as a point-of-care diagnostics[J]. J Glob Health, 2011, 1(2):201-209.
[14]
Mussap M, Noto A, Cibecchini F, et al. The importance of biomarkers in neonatology[J]. Semin Fetal Neonatal Med, 2013, 18(1):56-64.
[15]
Resch B, B R, N H. Comparison between pathogen associated laboratory and clinical parameters in early-onset sepsis of the newborn[J]. Open Microbiol J, 2016, 10:133-139.
[16]
Gerdes JS. Diagnosis and management of bacterial infections in the neonate[J]. Pediatr Clin North Am, 2004, 51(4):939-ix.
[17]
Odabasi IO, Bulbul A. Neonatal sepsis[J]. Sisli Etfal Hastan Tip Bul, 2020, 54(2):142-158.
Yang AP, Liu J, Yue LH, et al. Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis[J]. Clin Chem Lab Med, 2016, 54(2):345-351.
[20]
Al-Zahrani AKh, Ghonaim MM, Hussein YM, et al. Evaluation of recent methods versus conventional methods for diagnosis of early-onset neonatal sepsis[J]. J Infect Dev Ctries, 2015, 9(4):388-393.
LI Qian-Qian, DONG Xiao-Yue, QIAO Yu, YIN Yu-Jie, GAO Yan, ZHOU Jin-Jun, YANG Li, ZHU Rong-Ping, WANG Fu-Dong, WAN Jun, XU Yan, PAN Zhao-Jun, WANG Wei-Yuan, YAN Jun-Mei, HAN Shu-Ping, LU Hong-Yan, HU Yu-Hua, LI Shuang-Shuang, WANG Jin-Xiu, WU Ming-Fu, WANG Jun, DENG Xiao-Yi, YU Zhang-Bin. An investigation of severe neonatal hyperbilirubinemia in 13 hospitals of Jiangsu Province, China[J]. CJCP, 2020, 22(7): 690-695.
